News & Events

New research shows that youth who become increasingly addicted to social media, mobile phones or video games are at greater risk of suicidal thoughts, suicide attempts and emotional or behavioral issues. The study, published June 18 in JAMA, was led by researchers at Weill Cornell Medicine, Columbia University and University of California, Berkeley.

Unlike previous studies that focused on total screen time at...

Thousands of bacterial and other microbial species live in the human gut, supporting healthy digestion, immunity, metabolism and other functions. Precisely how these microbes are protected from immune attack has been unclear, but now a study led by Weill Cornell Medicine investigators has found that this immune “tolerance” to gut microbes depends on an ancient bacterial-sensing protein called STING—normally considered a trigger for inflammation. The surprising result could lead to new...

Dr. Teresa Sanchez, associate professor of pathology and laboratory medicine and associate professor of neuroscience in the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine, has been awarded the highly competitive Established Investigator Award from the American Heart Association.

The five-year, $550,000 grant supports mid-career...

Using an algorithm they call the Krakencoder, researchers at Weill Cornell Medicine are a step closer to unraveling how the brain’s wiring supports the way we think and act. The study, published June 5 in Nature Methods, used imaging data from the Human Connectome Project to align neural activity with its underlying circuitry.

Mapping...

At the 12th annual Helen and Robert Appel Alzheimer’s Disease Research Institute Symposium, scientists and clinicians shared their latest research which is advancing how Alzheimer’s disease is diagnosed and treated. Held at Weill Cornell Medicine’s Griffis Faculty Club, the symposium gave investigators and community members the opportunity to learn and ask questions about new directions in neurodegenerative research....

Dr. Arnab Ghosh, assistant professor of medicine at Weill Cornell Medicine, has been selected as an Emerging Leader in Health and Medicine Scholar. The program, part of the National Academy of Medicine, provides opportunities for future health care leaders to collaborate with its members...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.

The SERENA-6 study, published June 1 in the New England Journal of Medicine and presented concurrently...

When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic complexity.

A new study from researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) provides fresh insights about how cancers evolve when they metastasize — insights that could aid in developing strategies to improve the...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer.

Now, a team of researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) is expanding the understanding of how the...

Four Weill Cornell Medicine investigators received the Ritu Banga Healthcare Disparities Research Awards, recognizing innovative research that will help close care gaps in clinical settings. Endowed through a generous $5 million gift from Board of Fellows member Ritu Banga and her husband, Ajay Banga, each $50,000 award supports projects aimed at improving health outcomes for populations that have historically faced systemic barriers to care.

“It is an honor to help bring to life the...

Researchers at Weill Cornell Medicine have discovered how a parasite that causes malaria when transmitted through a mosquito bite can hide from the body’s immune system, sometimes for years. It turns out that the parasite, Plasmodium falciparum, can shut down a key set of genes, rendering itself “immunologically invisible.”

For six years, Dr. Benjamin Allwein studied to be a scientist at Weill Cornell Graduate School of Medical Sciences, immersed in structural biology and biochemistry. His educational journey investigating proteins involved in metabolism and DNA replication was intellectually rewarding, but it was also bookended by uncertainty and...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs. In the 72-week trial—led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian and conducted with the University of Texas McGovern Medical School, the David Geffen School of Medicine at the University of California, Los Angeles, the University College Dublin and...

A new artificial intelligence-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar outcomes after treatment, according to a study led by investigators at Weill Cornell Medicine. The new approach has the potential to enable better patient selection in clinical trials and better treatment selection for individual patients.

The study, published May 12 in...

Using machine learning technology, a new study has identified three distinct profiles describing social and economic factors that are associated with a higher risk of suicide. Scientists at Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons led the research that showed suicide rates vary significantly across the three clusters and that the patterns differ geographically across the United States.

The...

Weill Cornell Medicine has received a projected $4 million grant from the National Cancer Institute, part of the National Institutes of Health, to conduct a clinical trial testing whether a new imaging approach could reduce the need for biopsies to monitor prostate cancer.

The five-year grant, with a possible two-year extension, will evaluate whether adding an imaging modality called Prostate Specific Membrane Antigen (PSMA)- Positron Emission Tomography (PET) Computed Tomography (CT) ...

Weill Cornell Medicine-Qatar awarded Cornell University medical degrees to 45 new doctors during the institution’s commencement ceremony May 7.

The Class of 2025 comprised 28 women and 17 men who hail from 19 countries around the world, including 13 Qatari nationals. To date, WCM-Q has graduated 641 new doctors since its inaugural graduation ceremony in 2008.

“It is a great honor to be here to congratulate the Class of 2025 on their outstanding achievements,” said Cornell...

A tiny chemical modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress, according to a study led by Weill Cornell Medicine investigators.  The finding clarifies an important aspect of cell biology, and may have clinical implications, since this messenger RNA modification, known as m6A, is the target of an emerging class of cancer treatments.

Messenger RNA (mRNA)—the molecule that carries genetic instructions to make proteins—is...

As a third-year medical student, Stone Streeter cut his teeth during his medical education at Weill Cornell Medicine while living in the institution’s student housing—first at Olin Hall during his classroom instruction, then at Lasdon House for his clerkships. As he eyes his last year at Weill Cornell Medical College, he’s preparing for yet another move: to the Feil Family and Weill Family Residence Hall.

“Now, I’m standing here today, a mosaic of past experiences, ready to tackle the...